Prolactin stimulates cell proliferation through a long form of prolactin receptor and K+ channel activation

Biochemical Journal

Volumn 377, Issue 3, 2004, Pages 569-578

  Van Coppenolle, Fabien ^a   Skryma, Roman ^a   Ouadid Ahidouch, Halima ^a,c   Slomianny, Christian ^a   Roudbaraki, Morad ^a   Delcourt, Philippe ^a   Dewailly, Etienne ^a   Humez, Sandrine ^a   Crépin, Alexandre ^a   Gourdou, Isabelle ^b   Djiane, Jean ^b   Bonnal, Jean Louis ^a   Mauroy, Brigitte ^a   Prevarskaya, Natalia ^a  

^a Université des Sciences et Technologies de Lille   (France)

^b CEMAGREF   (France)

^c UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

Author keywords

LNCa cell; Patch clamp; Potassium channel; Prostate adenocarcinoma; Tyrosine kinase

Indexed keywords

ANTIBODIES; CELLS; TISSUE;

PHOSPHORYLATION;

BIOCHEMISTRY;

GENISTIN; HERBIMYCIN A; POTASSIUM CHANNEL; PROLACTIN; PROLACTIN RECEPTOR; PROTEIN TYROSINE KINASE INHIBITOR;

ARTICLE; CANCER CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; PATCH CLAMP; PRIORITY JOURNAL; PROBABILITY; PROSTATE CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 10744225953     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/bj20030859     Document Type: Article

References (64)

1. Nevalainen, M. T., Valve, E. M., Ingleton, P. M., Nurmi, M., Martikainen, P. M. and Harkonen, P. L. (1997) Prolactin and prolactin receptors are expressed and functioning in human prostate. J. Clin. Invest. 99, 618-627
2. Kadar, T., Ben-David, M., Pontes, J. E., Fekete, M. and Schally, A. V. (1988) Prolactin and luteinizing hormone-releasing hormone receptors in human benign prostatic hyperplasia and prostate cancer. Prostate 12, 299-307
3. Nevalainen, M. T., Valve, E. M., Ahonen, T., Yagi, A., Paranko, J. and Harkonen, P. L. (1997) Androgen-dependent expression of prolactin in rat prostate epithelium in vivo and in organ culture. FASEB J. 11, 1297-1307
4. Van Coppenolle, F., Le Bourhis, X., Carpentier, F., Delaby, G., Cousse, H., Raynaud, J. P., Dupouy, J. P. and Prevarskaya, N. (2000) Pharmacological effects of the lipidosterolic extract of Serenoa repens (Permixon) on rat prostate hyperplasia induced by hyperprolactinemia: comparison with finasteride. Prostate 43, 49-58
5. Van Coppenolle, F., Slomianny, C., Carpentier, F., Le Bourhis, X., Ahidouch, A., Croix, D., Legrand, G., Dewailly E., Fournier, S., Gousse, H. et al. (2001) Effects of hyperprolactinemia on rat prostate growth: evidence of androgen-dependence. Am. J. Physiol. Endocrinol. Metab. 280, E120-E129
6. Leff, M. A., Buckley, D. J., Krumenacker, J. S., Reed, J. C., Miyashita, T. and Buckley, A. R. (1996) Rapid modulation of the apoptosis regulatory genes, bcl-2 and bax by prolactin in rat Nb2 lymphoma cells. Endocrinology 137, 5456-5462
7. Nankin, H. R. and Calkins, J. H. (1986) Decreased bioavailable testosterone in aging normal and impotent men. J. Clin. Endocrinol. Metab. 63, 1418-1420
8. Ahonen, T. J., Harkonen, P. L., Laine, J., Rui, H., Martikainen, P. M. and Nevalainen, M.T. (1999) Prolactin is a survival factor for androgen-deprived rat dorsal and lateral prostate epithelium in organ culture. Endocrinology 140, 5412-5421
9. Goffin, V. and Kelly, P. A. (1997) The prolactin/growth hormone receptor family: structure/ function relationships. J. Mammary Gland Biol. Neoplasia 2, 7-17
10. Clevenger, C. V. and Medaglia, M. V. (1994) The protein tyrosine kinase P59fyn is associated with prolactin (PRL) receptor and is activated by PRL stimulation of T-lymphocytes. Mol. Endocrinol. 8, 674-681
11. Prevarskaya, N. B., Skryma, R. N., Vacher, P., Daniel, N., Djiane, J. and Dufy, B. (1995) Role of tyrosine phosphorylatjon in potassium channel activation. Functional association with prolactin receptor and JAK2 tyrosine kinase. J. Biol. Chem. 270, 24292-24299
12. Rui, H., Lebrun, J. J., Kirken, R. A., Kelly, P. A. and Farrar, W. L. (1994) JAK2 activation and cell proliferation induced by antibody-mediated prolactin receptor dimerization. Endocrinology 135, 1299-1306
13. DaSilva, L., Howard, O. M., Rui, H., Kirken, R. A. and Farrar, W. L. (1994) Growth signaling and JAK2 association mediated by membrane-proximal cytoplasmic regions of prolactin receptors. J. Biol. Chem. 269, 18267-18270
14. Seth, A., Gonzalez, F. A., Gupta, S., Raden, D. L. and Davis, R. J. (1992) Signal transduction within the nucleus by mitogen-activated protein kinase. J. Biol. Chem. 267, 24796-24804
15. Rui, H., Djeu, J. Y., Evans, G. A., Kelly, P. A. and Farrar, W. L. (1992) Prolactin receptor triggering. Evidence for rapid tyrosine kinase activation. J. Biol. Chem. 267, 24076-24081
16. Prevarskaya, N., Skryma, R., Vacher, P., Daniel, N., Bignon, C., Djiane, J. and Dufy, B. (1994) Early effects of PRL on ion conductances in CHO cells expressing PRL receptor. Am. J. Physiol. 267, C554-C562
17. Boutin, J. M., Edery, M., Shirota, M., Jolicoeur, C., Lesueur, L., Ali, S., Gould, D., Djiane, J. and Kelly, P. A. (1989) Identification of a cDNA encoding a long form of prolactin receptor in human hepatoma and breast cancer cells. Mol. Endocrinol. 3, 1455-1461
18. Kline, J. B., Roehrs, H. and Clevenger, C. V. (1999) Functional characterization of the intermediate isoform of the human prolactin receptor, J. Biol. Chem. 274, 35461-35468
19. Ruffion, A., Al-Sakkaf, K. A., Brown, B. L., Eaton, C. L., Hamdy, F. C. and Dobson, P. R. (2003) The survival effect of prolactin on PC3 prostate cancer cells. Eur. Urol. 43, 301-308
20. Bole-Feysot, C., Goffin, V., Edery, M., Binart, N. and Kelly, P. A. (1998) Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocrinol. Rev. 19, 225-268
21. Goffin, V. and Kelly, P. A. (2002) Growth-promoting actions of prolactin, the hormone of lactation. J. Pediatr. Endocrinol. Metab. 15, 787-788
22. Syms, A. J., Harper, M. E. and Griffiths, K. (1985) The effect of prolactin on human BPH epithelial cell proliferation. Prostate 6, 145-153
23. Horoszewicz, J. S., Leong, S. S., Kawinski, E., Karr, J. P., Rosenthal, H., Chu, T. M., Mirand, E. A. and Murphy, G. P. (1983) LNCaP model of human prostatic carcinoma. Cancer Res. 43, 1809-1818
24. Castagnetta, L. A., Miceli, M. D., Sorci, C. M., Pfeffer, U., Farruggio, R., Oliveri, G., Calabro, M. and Carruba, G. (1995) Growth of LNCaP human prostate cancer cells is stimulated by estradiol via its own receptor. Endocrinology 136, 2309-2319
25. Limonta, P., Dondi, D., Marelli, M. M., Moretti, R. M., Negri-Cesi, P. and Motta, M. (1995) Growth of the androgen-dependent tumor of the prostate: role of androgens and of locally expressed growth modulatory factors. J. Steroid Biochem. Mol. Biol. 53, 401-405
26. Skryma, R. N., Prevarskaya, N. B., Dufy-Barbe, L., Odessa, M. F., Audin, J. and Dufy, B. (1997) Potassium conductance in the androgen-sensitive prostate cancer cell line, LNCaP: involvement in cell proliferation. Prostate 33, 112-122
27. Skryma, R., Van Coppenolle, F., Dufy-Barbe, L., Dufy, B. and Prevarskaya, N. (1999) Characterization of Ca(2+)-inhibited potassium channels in the LNCaP human prostate cancer cell line. Receptors Channels 6, 241-253
28. Carlotti, A., Dallot, A., Laroche, L., Rybojad, M., Feyeux, C., Verola, O., Gisselbrecht, C., Morel, P. and Puissant, A. (1990) Cutaneous lymphomas of the T cell type presenting primary tumors. Curr. Probl. Dermatol. 19, 157-160
29. Gourdou, I., Gabou, L., Paly, J., Kermabon, A. Y., Belair, L. and Djiane, J. (1996) Development of a constitutively active mutant form of the prolactin receptor, a member of the cytokine receptor family. Mol. Endocrinol. 10, 45-56
30. Grynkiewicz, G., Poenie, M. and Tsien, R. Y. (1985) A new generation of Ca2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260, 3440-3450
31. Costello, L. C. and Franklin, R. B. (1994) Effect of prolactin on the prostate. Prostate 24, 162-166
32. Akiyama, T., Ishida, J., Nakagawa, S., Ogawara, H., Watanabe, S., Itoh, N., Shibuya, M. and Fukami, Y. (1987) Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 262, 5592-5595
33. O'Dell, T. J., Kandel, E. R. and Grant, S. G. (1991) Long-term potentiation in the hippocampus is blocked by tyrosine kinase inhibitors. Nature (London) 353, 558-560
34. Rui, H., Kirken, R. A. and Farrar, W. L. (1994) Activation of receptor-associated tyrosine kinase JAK2 by prolactin. J. Biol. Chem. 269, 5364-5368
35. Molokanova, E., Trivedi, B., Savchenko, A. and Kramer, R. H. (1997) Modulation of rod photoreceptor cyclic nucleotide-gated channels by tyrosine phosphorylation. J. Neurosci. 17, 9068-9076
36. Parekh, A. B. and Penner, R. (1997) Store depletion and calcium influx. Physiol. Rev. 77, 901-930
37. 2+-ATPase inhibitors. J. Immunol. 152, 5226-5240
38. 2+ transporter type 1. J. Biol. Chem. 278, 15381-15389
39. Vanden Abeele, F., Skryma, R., Shuba, Y., Van Coppenolle, F., Slomianny, C., Roudbaraki, M., Mauroy, B., Wuytack, F. and Prevarskaya, N. (2002) Bcl-2-dependent modulation of Ca(2+) homeostasis and store-operated channels in prostate cancer cells. Cancer Cell 1, 169-179
40. Soliven, B., Ma, L., Bae, H., Attali, B., Sobko, A. and Iwase, T. (2003) PDGF upregulates delayed rectifier via Src family kinases and sphingosine kinase in oligodendroglial progenitors. Am. J. Physiol. Cell Physiol. 284, C85-C93
41. Sobko, A., Peretz, A. and Attali, B. (1998) Constitutive activation of delayed-rectifier potassium channels by a src family tyrosine kinase in Schwann cells. EMBO J. 17, 4723-4734
42. 2+ channels in Chinese hamster ovary cells stably expressing prolactin receptor. J. Mol. Endocrinol. 21, 85-95
43. Wang, Y. F., Jia, H., Walker, A. M. and Cukierman, S. (1992) K-current mediation of prolactin-induced proliferation of malignant (Nb2) lymphocytes. J. Cell Physiol. 152, 185-189
44. + channel block-induced mammalian neuroblastoma cell swelling: a possible mechanism to influence proliferation. J. Physiol. 510, 93-102
45. Vaur, S., Bresson-Bepoldin, L., Dufy, B., Tuffet, S. and Dufy-Barbe, L. (1998) Potassium channel inhibition reduces cell proliferation in the GH3 pituitary cell line. J. Cell Physiol. 177, 402-410
46. Shieh, C. C., Coghlan, M., Sullivan, J. P. and Gopalakrishnan, M. (2000) Potassium channels: molecular defects, diseases, and therapeutic opportunities. Pharmacol. Rev. 52, 557-594
47. Wickenden, A. (2002) K(+) channels as therapeutic drug targets. Pharmacol. Ther. 94, 157-182
48. Nilius, B. and Wohlrab, W. (1992) Potassium channels and regulation of proliferation of human melanoma cells. J. Physiol. 445, 537-548
49. + channel. Receptors Channels 7, 345-356
50. Pardo, L. A., del Camino, D., Sanchez, A., Alves, F., Bruggemann, A., Beckh, S. and Stuhmer, W. (1999) Oncogenic potential of EAG K(+) channels. EMBO J. 18, 5540-5547
51. + channels. J. Cell Biol. 143, 767-775
52. + channel gating. Mol. Pharmacol. 59, 1376-1387
53. Ouadid-Ahidouch, H., Chaussade, F., Roudbaraki, M., Slomianny, C., Dewailly, E., Delcourt, P. and Prevarskaya, N. (2000) KV1.1 K(+) channels identification in human breast carcinoma cells: involvement in cell proliferation. Biochem. Biophys. Res. Commun. 278, 272-277
54. Ivanov, D. V., Tyazhelova, T. V., Lemonnier, L., Kononenko, N., Pestova, A. A., Nikitin, E. A., Prevarskaya, N., Skryma, R., Panchin, Y. V., Yankovsky, N. K. and Baranova, A. V. (2003) A new human gene KCNRG encoding potassium channel regulating protein is a cancer suppressor gene candidate located in 13q14.3. FEBS Lett. 539, 156-160
55. Sorin, B., Goupille, O., Vacher, A. M., Paly, J., Djiane, J. and Vacher, P. (1998) Distinct cytoplasmic regions of the prolactin receptor are required for prolactin-induced calcium entry. J. Biol. Chem. 273, 28461-28469
56. Ullrich, A., Bell, J. R., Chen, E. Y., Herrera, R., Petruzzelli, L. M., Dull, T. J., Gray, A., Coussens, L., Liao, Y. C., Tsubokawa, M. et al. (1985) Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. Nature (London) 313, 756-761
57. Peppelenbosch, M. P., Tertoolen, L. G. and de Laat, S. W. (1991) Epidermal growth factor-activated calcium and potassium channels. J. Biol. Chem. 266, 19938-19944
58. Reinhart, P. H. and Levitan, I. B. (1995) Kinase and phosphatase activities intimately associated with a reconstituted calcium-dependent potassium channel. J. Neurosci. 15, 4572-4579
59. Holmes, T. C., Fadool, D. A., Ren, R. and Levitan, I. B. (1996) Association of Src tyrosine kinase with a human potassium channel mediated by SH3 domain. Science 274, 2089-2091
60. Yu, X. M., Askalan, R., Keil, 2nd, G. J. and Salter, M. W. (1997) NMDA channel regulation by channel-associated protein tyrosine kinase Src. Science 275, 674-678
61. Molokanova, E., Savchenko, A. and Kramer, R. H. (1999) Noncatalytic inhibition of cyclic nucleotide-gated channels by tyrosine kinase induced by genistein. J. Gen. Physiol. 113, 45-56
62. Aniksztejn, L., Catarsi, S. and Drapeau, P. (1997) Channel modulation by tyrosine phosphorylation in an identified leech neuron. J. Physiol. 498, 135-142
63. Waters, M. J., Daniel, N., Bignon, C. and Djiane, J. (1995) The rabbit mammary gland prolactin receptor is tyrosine-phosphorylated in response to prolactin in vivo and in vitro. J. Biol. Chem. 270, 5136-5143
64. Lebrun, J. J., Ali, S., Sofer, L., Ullrich, A. and Kelly, P. A. (1994) Prolactin-induced proliferation of Nb2 cells involves tyrosine phosphorylation of the prolactin receptor and its associated tyrosine kinase JAK2. J. Biol. Chem. 269, 14021-14026